Table 2.
N (M/F) | Participants Age (years) |
n-3 PUFA (% in diet) | Other diet | Duration | Body weight | Fat mass | Fat site | Lean mass | Energy intake | Ref. |
---|---|---|---|---|---|---|---|---|---|---|
15 (10/5) | Healthy adults 69–73 years |
4 g Lovaza/day 1.86 g EPA 1.50 g DHA |
Corn oil NA |
8 weeks | NC | NC | NA | NC | [186] | |
44(15/29) | Healthy adults 62–76 years |
4 g n-3 1.86 g EPA 1.5 g DHA |
Corn oil | 6 months | NC | NC | NA | + | NA | [210] |
17 (8/9) | Nonobese, T2DM Obese, T2DM 41–66 years |
PUFA diet NA |
SF diet | 10 weeks 5 week crossover design |
NC | − | Abdominal SubQ | NA | NC | [71] |
33 (20/13) | Overweight, impaired glucose 40–61 years |
3.9 g EPA + DHA | Maize oil | 9 months | NC | NC | NA | NC | NA | [187] |
53 (17/36) | Decreased muscle mass 60+ years |
1.3 g n-3 660 mg EPA 440 mg DHA |
Vitamin E | 12 weeks | NC | NC | NA | NC | NA | [211] |
76 | Overweight, IR 9–18 years |
540 mg EPA 360 mg DHA |
Corn starch | 1 month | NC | NC | NA | NA | NA | [126] |
126 F | Healthy, postmenopausal 68–82 years |
1.2 g EPA + DHA | Olive oil | 6 months | NC | NA | NA | NA | NC | [70] |
44 (14/30) | Healthy 27–41 years |
1.6 g EPA 800 mg DHA |
Safflower oil | 6 weeks | NC | − | NA | + | NA | [66] |
12 F | Postmenopausal, T2DM, without hypertriglyceridemia 54–56 years |
1.8 g n-3 1.08 EPA 0.72 DHA |
Placebo Paraffin oil |
2 months | NC | − | SubQ | NA | NC | [69] |
47 M | Overweight 35–55 years |
230 mg EPA and 154 mg DHA | Corn oil | 8 weeks | NC | NA | NA | NA | NC | [68] |
66 (45/21) | T2DM 40–70 years |
2.8 g EPA + DHA | Placebo | 24 weeks | NC | NA | NA | NA | NA | [208] |
24 M | Viscerally Obese | 1.8 g EPA + 1.56g EPA | Placebo | 6 weeks | NC | NA | NA | NA | NA | [212] |
27F | Overweight/obese 23–60 years |
2.8 g DHA | Oleic acid | 12 weeks | NC | NC | NA | NC | − | [67] |
F, female; IR, insulin resistant; M, male.